Evidence map›Paper›PMID 33059832›Full record

ArticleJournal of the American College of Cardiology2020

Molecular Imaging of Apoptosis in Atherosclerosis by Targeting Cell Membrane Phospholipid Asymmetry.

Farhan Chaudhry, Hideki Kawai, Kipp W Johnson, Navneet Narula, Aditya Shekhar, Fayzan Chaudhry, Takehiro Nakahara, Takashi Tanimoto, Dongbin Kim, Matthew K M Y Adapoe and 10 more

Abstract read
In one paragraph

Article in Journal of the American College of Cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Radionuclide imaging of apoptosis for clinical application.European journal of nuclear medicine and molecular imaging · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Farhan ChaudhryIcahn School of Medicine at Mount Sinai, New York, New York; Wayne State University School of Medicine, Detroit, Michigan.
Hideki KawaiIcahn School of Medicine at Mount Sinai, New York, New York; Department of Cardiology, Fujita Health University, Toyoake, Aichi, Japan.
Kipp W JohnsonIcahn School of Medicine at Mount Sinai, New York, New York.
Navneet NarulaNew York University Langone Medical Center, New York, New York.
Aditya ShekharIcahn School of Medicine at Mount Sinai, New York, New York.
Fayzan ChaudhryIcahn School of Medicine at Mount Sinai, New York, New York.
Takehiro NakaharaIcahn School of Medicine at Mount Sinai, New York, New York.
Takashi TanimotoIcahn School of Medicine at Mount Sinai, New York, New York.
Dongbin KimIcahn School of Medicine at Mount Sinai, New York, New York.
Matthew K M Y AdapoeIcahn School of Medicine at Mount Sinai, New York, New York.
Francis G BlankenbergLucile Salter Packard Children's Hospital, Stanford, California.
Jeffrey A MattisMolecular Targeting Technologies, Inc., West Chester, Pennsylvania.
Koon Y PakMolecular Targeting Technologies, Inc., West Chester, Pennsylvania.
Phillip D LevyWayne State University School of Medicine, Detroit, Michigan.
Yukio OzakiDepartment of Cardiology, Fujita Health University, Toyoake, Aichi, Japan.
Eloisa ArbustiniPoliclinico San Matteo Pavia Fondazione IRCCS, Pavia, Italy.
H William StraussIcahn School of Medicine at Mount Sinai, New York, New York; Memorial Sloan Kettering Cancer Center, New York, New York.
Artiom PetrovIcahn School of Medicine at Mount Sinai, New York, New York. Electronic address: artiom.petrov@mssm.edu.
Valentin FusterIcahn School of Medicine at Mount Sinai, New York, New York; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
Jagat NarulaIcahn School of Medicine at Mount Sinai, New York, New York.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748NHLBI NIH HHS HHSN268201400043C
6 · The paper itself

Abstract

backgroundApoptosis in atherosclerotic lesions contributes to plaque vulnerability by lipid core enlargement and fibrous cap attenuation. Apoptosis is associated with exteriorization of phosphatidylserine (PS) and phosphatidylethanolamine (PE) on the cell membrane. Although PS-avid radiolabeled annexin-V has been employed for molecular imaging of high-risk plaques, PE-targeted imaging in atherosclerosis has not been studied.

objectivesThis study sought to evaluate the feasibility of molecular imaging with PE-avid radiolabeled duramycin in experimental atherosclerotic lesions in a rabbit model and compare duramycin targeting with radiolabeled annexin-V.

methodsOf the 27 rabbits, 21 were fed high-cholesterol, high-fat diet for 16 weeks. Nine of the 21 rabbits received

resultsA significantly higher duramycin uptake was observed in the test group compared with that of disease control and negative radiotracer control animals; duramycin uptake was also significantly higher than the annexin-V uptake. Quantitative duramycin uptake, represented as the square root of percent injected dose per cm (√ID/cm) of abdominal aorta was >2-fold higher in atherosclerotic lesions in test group (0.08 ± 0.01%) than in comparable regions of disease control animals (0.039 ± 0.0061%, p = 3.70·10

conclusionsRadiolabeled duramycin localizes in lipid-rich areas with high concentration of apoptotic macrophages in the experimental atherosclerosis model. Duramycin uptake in atherosclerotic lesions was significantly greater than annexin-V uptake and produced significantly lower radiation burden to nontarget organs.

Indexed as

AnimalsApoptosisAtherosclerosisBacteriocinsCell MembraneDiet, High-FatHumansMaleMolecular ImagingPeptidesPhospholipidsRabbitsRadionuclide ImagingBacteriocinsduramycinPeptidesPhospholipidsannexin-Vcell deathduramycinradionuclide imagingvulnerable plaques

Identifiers

PMID33059832
PMCPMC7654709

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.